Dornier MedTech Revenue and Competitors

Dornier MedTech, known as a pioneer and market leader in the urology market, continues to provide innovative therapeutic, diagnostic and service solutions worldwide for numerous healthcare fields. Working closely with other leading medical organizations, Dornier develops, manufactures, markets and services lithotripters, orthopedic shock wave devices, urotables, surgical lasers, medical aesthetic lasers - and more. Dornier MedTech is headquartered in Munich, Germany, and its principal shareholders are Accuron Technologies, Ltd. and DaimlerChrysler. As the inventor of the first lithotripter and extracorporeal shockwave lithotripsy (ESWL), Dornier continues to revolutionize the urology market with distinctive lithotripters and urology imaging tables and has the largest installed base of over 1,000 lithotripters worldwide. Using this innovative technology, Dornier further developed extracorporeal shockwave therapy (ESWT), the treatment principle for its orthopaedic shockwave device. Dornier also sets new standards in laser surgery with the continued development of quality solid state lasers. With several thousand installations of Dornier Medilas lasers worldwide, Dornier uses their expertise and experience to develop highly advanced systems to be used for a variety of treatments.